Treatment trends in early-stage invasive lobular carcinoma: A report from the National Cancer Data Base

Annals of Surgery

Volumn 242, Issue 2, 2005, Pages 281-289

  Singletary, S Eva ^a   Patel Parekh, Lina ^b   Bland, Kirby I ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST SURGERY; CANCER RECURRENCE; CANCER REGISTRY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT PLANNING; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, LOBULAR; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY; UNITED STATES;

EID: 22744444507     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000171306.74366.22     Document Type: Article

References (34)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-1232.
3. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med. 1998;339:941-6.
4. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91:368-373.
5. Arpino G, Bardou VJ, Clark GM, et al. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6:R149-R156.
6. Selinko VL, Middleton LP, Dempsey PJ. Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound. 2004;32:323-332.
7. Pritt B, Ashikaga T, Oppenheimer RG, et al. Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements. Mod Pathol. 2004;17:905-910.
8. Weinstein SP, Orel SG, Heller R, et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol. 2001; 176:399-406.
9. Yeatman TJ, Cantor AB, Smith TJ, et al. Tumor biology of infiltrating lobular carcinoma: implications for management. Ann Surg. 1995;222: 549-561.
10. Ashikari R, Huvos AG, Urban JA, et al. Infiltrating lobular carcinoma of the breast. Cancer. 1973;31:110-116.
11. Grube BJ, Hansen NM, Ye X, et al. Tumor characteristics predictive of sentinel node metastases in 105 consecutive patients with invasive lobular carcinoma. Am J Surg. 2002;184:372-376.
12. du Toit RS, Locker AP, Ellis IO, et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol. 1991;17:251-257.
13. Holland P, Shah A, Howell A, et al. Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg. 1991;82:1364-1366.
14. Hussein M, Lioe TF, Finnegan J, et al. Surgical treatment for invasive lobular carcinoma of the breast. Breast. 2003;12:23-35.
15. Bouvet M, Ollila DW, Hunt KK, et al. Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:650-654.
16. Kurtz JM, Jacquemier J, Torhorst J, et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer. 1989; 63:1630-635.
17. Schnitt SJ, Connolly JL, Harris JR, et al. Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer. 1984;53:1049-1057.
18. Calle R, Vilcoq JR, Zafrani B, et al. Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int J Radiat Oncol Biol Phys. 1986;12:873-878.
19. Mate TP, Carter D, Fischer DB, et al. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer. 1986;58:1995-2002.
20. Weiss MC, Fowble B, Solin LJ, et al. Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys. 1992;23:941-947.
21. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Cancer. 1996;77:113-120.
22. Harris EE, Hwang W, Santiago R, et al. Long-term outcomes for breast conservation therapy in invasive lobular carcinoma of the breast. Int J Radiat Oncol Biol Phys. 2003;57(suppl 2):359-360.
23. Warneke J, Berger R, Johnson C, et al. Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast. Am J Surg. 1996;172:496-500.
24. Chung MA, Cole B, Wanebo JH, et al. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:545-550.
25. Winchester DJ, Chang HR, Graves TA, et al. A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg. 1998;186:416-422.
26. Coates RJ, Marchbanks PA, Norman SA, et al. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer. 2002;95:2455-2464.
27. Li CI, Malone KE, Porter PL, et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA. 2003;289:3254-3263.
28. Osteen RT, Steele GD, Menck HR, et al. Regional differences in surgical management of breast cancer. CA Cancer J Clin. 1992;42:39-43.
29. Albain KS, Green SR, Lichter AS, et al. Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol. 1996;14: 3009-3017.
30. Classe JM, Loussouarn D, Campion L, et al. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study. Cancer. 2004;100:935-941.
31. Edge SB, Niland JC, Bookman MA, et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst. 2003;95:1514-1521.
32. Sabel MS, Degnim A, Wilkins EG, et al. Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer. Am J Surg. 2004;187:673-678.
33. Brady B, Fant J, Jones R, et al. Sentinel lymph node biopsy followed by delayed mastectomy and reconstruction. Am J Surg. 2003;185:114-117.
34. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst. 2000;92:550-556.